AVITA Medical, Inc. (RCEL)
NASDAQ: RCEL · IEX Real-Time Price · USD
9.67
-0.29 (-2.91%)
At close: Jul 19, 2024, 4:00 PM
9.59
-0.08 (-0.83%)
Pre-market: Jul 20, 2024, 9:29 AM EDT
AVITA Medical Revenue
AVITA Medical had revenue of $51.50M in the twelve months ending March 31, 2024, with 27.03% growth year-over-year. Revenue in the quarter ending March 31, 2024 was $11.10M. In the year 2023, AVITA Medical had annual revenue of $51.57M with 37.03% growth.
Revenue (ttm)
$51.50M
Revenue Growth
+27.03%
P/S Ratio
4.84
Revenue / Employee
$248,783
Employees
207
Market Cap
249.48M USD
Revenue Chart
* The company reports in AUD currency but revenue data is shown in USD.
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2023 | 51.57M | 13.94M | 37.03% |
Dec 31, 2022 | 37.64M | 3.02M | 8.73% |
Dec 31, 2021 | 34.62M | 16.43M | 90.31% |
Jun 30, 2020 | 18.19M | 6.79M | 59.62% |
Jun 30, 2019 | 11.40M | 2.73M | 31.54% |
Jun 30, 2018 | 8.66M | 3.53M | 68.74% |
Jun 30, 2017 | 5.13M | 3.33M | 184.18% |
Jun 30, 2016 | 1.81M | - | - |
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
AirSculpt Technologies | 197.72M |
Codexis | 74.23M |
Utah Medical Products | 49.04M |
Nanobiotix | 40.23M |
Zevra Therapeutics | 28.01M |
Senseonics Holdings | 23.30M |
Profound Medical | 5.33M |
Immutep | 4.58M |
RCEL News
- 10 days ago - AVITA Medical to Announce Second Quarter 2024 Financial Results - GlobeNewsWire
- 20 days ago - AVITA Medical Appoints Nicole Kelsey as Chief Legal and Compliance Officer, and Corporate Secretary - GlobeNewsWire
- 6 weeks ago - AVITA Medical Achieves Milestone with First Case Using RECELL GO - GlobeNewsWire
- 7 weeks ago - AVITA Medical Announces FDA Approval of RECELL GO - GlobeNewsWire
- 2 months ago - AVITA Medical to Host Investor Webinar Briefing - GlobeNewsWire
- 2 months ago - AVITA Medical Reports First Quarter Financial Results - GlobeNewsWire
- 3 months ago - AVITA Medical to Announce First Quarter 2024 Financial Results - GlobeNewsWire
- 3 months ago - AVITA Medical Updates Expected First Quarter 2024 Revenue - GlobeNewsWire